InChI=1S/C21H26N2OS2.C6H6O3S/c1- 22- 13- 6- 5- 7- 16(22) 12- 14- 23- 18- 8- 3- 4- 9- 20(18) 25- 21- 11- 10- 17(26(2) 24) 15- 19(21) 23;7- 10(8,9) 6- 4- 2- 1- 3- 5- 6/h3- 4,8- 11,15- 16H,5- 7,12- 14H2,1- 2H3;1- 5H,(H,7,8,9) |
CRJHBCPQHRVYBS-UHFFFAOYSA-N |
OS(=O)(=O)c1ccccc1.CN1CCCCC1CCN1c2ccccc2Sc2ccc(cc12)S(C)=O |
|
dopaminergic antagonist
A drug that binds to but does not activate dopamine receptors, thereby blocking the actions of dopamine or exogenous agonists.
|
|
dopaminergic antagonist
A drug that binds to but does not activate dopamine receptors, thereby blocking the actions of dopamine or exogenous agonists.
first generation antipsychotic
Antipsychotic drugs which can have different modes of action but which tend to be more likely than second generation antipsychotics to cause extrapyramidal motor control disabilities such as body rigidity or Parkinson's disease-type movements; such body movements can become permanent even after treatment has ceased.
|
|
View more via ChEBI Ontology
10-[2-(1-methylpiperidin-2-yl)ethyl]-2-(methylsulfinyl)-10H-phenothiazine benzenesulfonate
|
(±)-10-(2-(1-methyl-2-piperidyl)ethyl)-2-(methylsulfinyl)phenothiazine monobenzenesulfonate
|
ChemIDplus
|
10-(2-(1-methyl-2-piperidyl)ethyl)-2-(methylsulfinyl)phenothiazine monobenzenesulfonate
|
ChemIDplus
|
mesoridazine benzenesulfonate
|
ChemIDplus
|
mesoridazine monobenzenesulfonate
|
ChEBI
|
NC 123
|
ChemIDplus
|
thioridazine-2-sulfoxide besylate
|
ChEBI
|
Lidanar
|
ChEBI
|
Lidanil
|
ChEBI
|
Serentil
|
ChEBI
|
Serentil
|
KEGG DRUG
|
32672-69-8
|
CAS Registry Number
|
ChemIDplus
|
32672-69-8
|
CAS Registry Number
|
KEGG DRUG
|
4121451
|
Reaxys Registry Number
|
Reaxys
|
|